Behavioral Intervention Trial for HIV-infected Injection Drug Users

Completed · Phase 2/Phase 3

Conditions studied: HIV

In brief

The purpose of this study is to test whether a ten-session behavioral intervention for HIV-infected injection drug users is effective in reducing sex and injection risk behaviors that put others at risk for HIV infection, increasing access to or utilization of HIV primary health care, and increasing adherence to HIV medications.

Key facts

Study ID

NCT00146445

Run by

Centers for Disease Control and Prevention

People needed

1000

Starts

2001-08-01

Expected to finish

2006-07-01

Last updated by the study team

2012-09-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• self-identify as a person who has injected drugs in the last 12 months
• self-identify as a person who has had sex with at least one opposite sex partner within the last 3 months
• self-identify as HIV-seropositive
• be confirmed as HIV seropositive through oral fluid (saliva) HIV testing
• live in the geographic region under study,
• agree to have their blood drawn for CD4 count and viral load testing
• be willing to provide basic contact information (for follow-up)
• be able to communicate in English
• not have participated in the full-pilot of this intervention and not have enrolled previously in the present study.

Where it is running

• University of California - San Francisco — San Francisco, California, United States
• University of Miami — Miami, Florida, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• New York Academy of Medicine — New York, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.